NAT2 and tuberculosis: Stratified or personalized approaches to treatment of drug-sensitive tuberculosis have also been proposed: The pharmacokinetics (PK) of INH are strongly determined by the highly polymorphic NAT2 gene [5] and precision dosing approaches may be associated with fewer adverse events and improved outcomes in Asian populations [6, 7].